Insider Trading History of North Annette

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of North Annette since 2021. This trader's CIK number is 1341011. At the time of last reporting, North Annette was the EVP & General Counsel of Turning Point Therapeutics, Inc.. (stock ticker symbol TPTX). Also see all insider trading activities at Turning Point Therapeutics, Inc..


Yearly summary of insider trading at Turning Point Therapeutics, Inc. (TPTX) by North Annette

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 TPTX 0 $0 669 $24,284 0 $0
2021 TPTX 0 $0 70,000 $7,281,397 75,882 $1,289,994


Insider trading of Turning Point Therapeutics, Inc. (TPTX) by North Annette

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-02-09 TPTX Sale 669 36.30 24,284
2021-08-30 TPTX Option Ex 10,000 17.00 170,000
2021-08-30 TPTX Sale 10,000 80.00 800,000
2021-06-15 TPTX Sale 15,000 77.04 1,155,645
2021-06-15 TPTX Option Ex 15,000 17.00 255,000
2021-05-06 TPTX Option Ex 5,882 17.00 99,994
2021-03-08 TPTX Option Ex 20,000 17.00 340,000
2021-03-08 TPTX Sale 20,000 108.95 2,178,960
2021-02-01 TPTX Option Ex 15,984 17.00 271,728
2021-02-02 TPTX Option Ex 9,016 17.00 153,272
2021-02-01 TPTX Sale 15,984 123.97 1,981,456
2021-02-02 TPTX Sale 9,016 129.25 1,165,336

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by North Annette (EVP & General Counsel of Turning Point Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.